Related Experiment Videos

[Course of aortic valve insufficiency in percutaneous aortic valvuloplasty]

V Voudris1, G Drobinski, I Sotirov

  • 1Service de cardiologie, CHU Pitié-Salpêtrière, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 1, 1989
PubMed

Insights

Percutaneous aortic valvuloplasty carries a low risk of worsening aortic regurgitation. Mild or moderate leakage should not prevent patients with aortic valve stenosis from undergoing this procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Context:

  • Percutaneous aortic valvuloplasty (PAV) is a treatment for severe aortic valve stenosis.
  • Assessing the impact of PAV on aortic regurgitation (AR) is crucial for patient selection and procedural success.

Purpose:

  • To evaluate the risk of new or aggravated aortic regurgitation following percutaneous aortic valvuloplasty using angiography.
  • To determine if pre-existing mild or moderate aortic regurgitation influences the decision to perform PAV.

Summary:

  • Angiography in 50 patients undergoing PAV showed that 41 had no change in aortic regurgitation.
  • Minute leakage developed in one patient; regurgitation decreased or resolved in eight patients.
  • The study suggests PAV has a low risk of causing significant aortic regurgitation, with observed improvements in some cases.

Impact:

  • Findings indicate that mild to moderate aortic regurgitation should not be a contraindication for PAV in patients with aortic valve stenosis.
  • This supports the expanded use of PAV as a viable treatment option for selected patients.
  • The study contributes to understanding the safety profile of PAV regarding valvular competence.

Related Concept Videos